Population-based Study for Metabolomics Biomarkers Identification and Risk Prediction Model Construction for Esophageal Squamous Cell Carcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023091

Enrollment

Unknown

Registered

2019-05-10

Start date

2013-06-01

Completion date

Unknown

Last updated

2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

Index test:metabolic biomarkers

Gold Standard:Pathological examination

Eligibility

Sex/Gender

All

Age

40 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1) Residents in Feicheng; 2) Aged 40-69 years.

Exclusion criteria

Exclusion criteria: 1) Refusing to participate in any parts of this study. 2) Working outside Feicheng more than six months a year. 3) Having endoscopy contraindications. 4) Having an iodine allergy or hyperthyroidism. 5) Take any medications, surgery, radiotherapy or chemotherapy. 6) Suffering from metabolic diseases, liver diseases, kidney diseases or any other cancers.

Design outcomes

Primary

Measure	Time frame
metabolic biomarkers;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactJialin Wang

Shandong Cancer Hospital and Institute

wangjialin6681@163.com+86 15553119217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026